Investigation of Antibody-Dependent Enhancement (ADE) of SARS coronavirus infection and its role in pathogenesis of SARS
2011

Study on Antibody-Dependent Enhancement of SARS Coronavirus Infection

publication Evidence: moderate

Author Information

Author(s): Yip Ming S, Cheung Chung Y, Li Ping H, Bruzzone Roberto, Peiris JS Malik

Primary Institution: HKU-Pasteur Research Centre, Hong Kong

Hypothesis

Can SARS-CoV use antibody-dependent enhancement mechanisms to increase its infectivity towards human immune cells?

Conclusion

SARS-CoV can enter human immune cells through an antibody-mediated pathway, raising concerns about the use of SARS-CoV vaccines in humans.

Supporting Evidence

  • SARS-CoV can use antibody-mediated pathways to enter human immune cells.
  • Only anti-SARS-CoV Spike serum induced a significant increase in viral genes and proteins in Raji B cells.
  • The study raises concerns about the safety of SARS-CoV vaccines in humans.

Takeaway

This study found that a virus called SARS-CoV can sneak into immune cells using antibodies, which might make vaccines less safe.

Methodology

The study involved using heat-inactivated immune serum from vaccinated rodents to test infection of human immune cells with SARS-CoV.

Limitations

The study could not directly assess productive replication due to the low percentage of infected cells.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication